SHENZHEN, China, July 20 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will report its financial results for the second quarter ended June 30, 2010 after the U.S. market closes on August 9, 2010. Mindray's management will hold an earnings conference call at 8:00 AM on August 10, 2010 U.S. Eastern Time (8:00 PM on August 10, 2010 Beijing/Hong Kong Time).
Dial-in details for the earnings conference call are as follows: Hong Kong: +852-3002-1672 U.S. Toll Free: +1-866-383-8108 International: +1-617-597-5343 Passcode for all regions: Mindray
A replay of the conference call may be accessed by phone at the following numbers until August 24, 2010.
U.S. Toll Free: +1-888-286-8010 International: +1-617-801-6888 Passcode: 3017 2538
Additionally, a live and archived webcast of this conference call will be available on the Investor Relations section of Mindray's website at http://ir.mindray.com .
We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://www.mindray.com .
For investor and media inquiries please contact: In the U.S.: John Capodanno FD Tel: +1-212-850-5705 Email: firstname.lastname@example.org Bryan Armstrong FD Tel: +1-312-553-6707 Email: email@example.com In China: May Li Mindray Medical International Limited Tel: +86-755-2658-2518 Email: firstname.lastname@example.org
|SOURCE Mindray Medical International Limited|
Copyright©2010 PR Newswire.
All rights reserved